SMISEK JEFFERY A 4
4 · Finch Therapeutics Group, Inc. · Filed Mar 29, 2024
Insider Transaction Report
Form 4
SMISEK JEFFERY A
Director
Transactions
- Sale
Common Stock
2024-03-28$2.61/sh−1,600$4,176→ 6,512 total(indirect: By Spouse) - Sale
Common Stock
2024-03-28$2.57/sh−6,642$17,070→ 0 total
Holdings
- 40,260(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]Represents the weighted-average price of shares sold by the broker on behalf of the Reporting Person. The broker sold, in the aggregate on behalf of such Reporting Person, 6,642 shares in transactions ranging from $2.48 to $2.75 with a weighted-average price of $2.57. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]Represents the weighted-average price of shares sold by the broker on behalf of the Reporting Person's spouse. The broker sold, in the aggregate on behalf of such Reporting Person's spouse, 1,600 shares in transactions ranging from $2.56 to $2.76 with a weighted-average price of $2.61. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The securities are held by Flight Partners Management LLC ("Flight Partners Capital"). The Reporting Person is the president of Flight Partners Capital.